Cargando…
STAT3/NF‐κB signalling disruption in M2 tumour‐associated macrophages is a major target of PLGA nanocarriers/PD‐L1 antibody immunomodulatory therapy in breast cancer
BACKGROUND AND PURPOSE: Inflammation associated with the tumour microenvironment (TME) is critical for cancer development, and immunotherapeutic strategies modulating the immune response in cancer have been crucial. In this study, a methotrexate‐loaded (MTX) poly(lactic‐co‐glycolic acid)‐based (PLGA...
Autores principales: | Cavalcante, Rômulo S., Ishikawa, Uta, Silva, Emanuell S., Silva‐Júnior, Arnóbio A., Araújo, Aurigena A., Cruz, Luis J., Chan, Alan B., de Araújo Júnior, Raimundo F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251773/ https://www.ncbi.nlm.nih.gov/pubmed/33434950 http://dx.doi.org/10.1111/bph.15373 |
Ejemplares similares
-
Metformin Hydrochloride-Loaded PLGA Nanoparticle in Periodontal Disease Experimental Model Using Diabetic Rats
por: Pereira, Aline de Sousa Barbosa Freitas, et al.
Publicado: (2018) -
In vitro-in vivo availability of metformin hydrochloride-PLGA nanoparticles in diabetic rats in a periodontal disease experimental model
por: Pereira, Aline de Sousa Barbosa Freitas, et al.
Publicado: (2021) -
Effect of Dexamethasone-Loaded PLGA Nanoparticles on Oral Mucositis Induced by 5-Fluorouracil
por: Ribeiro, Susana Barbosa, et al.
Publicado: (2021) -
Retinoic acid-loaded PLGA nanocarriers targeting cell cholesterol potentialize the antitumour effect of PD-L1 antibody by preventing epithelial-mesenchymal transition mediated by M2-TAM in colorectal cancer
por: Júnior, Raimundo Fernandes de Araújo, et al.
Publicado: (2023) -
Cationic PLGA Nanoparticle Formulations as Biocompatible Immunoadjuvant for Serum Production and Immune Response against Bothrops jararaca Venom
por: dos Santos-Silva, Emanuell, et al.
Publicado: (2022)